Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide notice announces an NIH website transition and says that some NIH content will use “Super Intelligence” in place of “Artificial Intelligence”.
    Difference
    1%
    Check dated 2026-10-25T15:48:58.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision updated from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:44:19.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T20:53:24.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating the page is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-20T22:31:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study page no longer displays the 'Melanoma' disease label or the 'MedlinePlus Genetics' related topics link, altering the disease context and available related resources on the page.
    Difference
    0.2%
    Check dated 2026-09-13T19:19:47.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics as a related topic in the study’s metadata. This expands the contextual keywords and helps link the trial to related resources without changing the trial's substantive details.
    Difference
    0.2%
    Check dated 2026-09-06T22:29:22.000Z thumbnail image

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.